Arcellx Quarterly Balance Sheets Chart
Quarterly
|
Annual
Arcellx Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | |||||||||||||||
| current assets: | |||||||||||||||
| cash and cash equivalents | 62,336,000 | 80,861,000 | 105,679,000 | 161,846,000 | 100,025,000 | 154,574,000 | 394,583,000 | 126,119,000 | 303,665,000 | 274,892,000 | 64,179,000 | 56,763,000 | 164,540,000 | 127,160,000 | 30,833,000 |
| marketable securities | 390,767,000 | 462,404,000 | 481,696,000 | 412,408,000 | 416,663,000 | 419,345,000 | 307,434,000 | 313,597,000 | 202,819,000 | 258,701,000 | 190,656,000 | 224,018,000 | 142,446,000 | 83,769,000 | 73,784,000 |
| restricted cash, current | 208,000 | 208,000 | 208,000 | 208,000 | 208,000 | 1,903,000 | |||||||||
| prepaid expenses and other current assets | 10,792,000 | 10,681,000 | 11,727,000 | 12,839,000 | 13,307,000 | 14,606,000 | 12,443,000 | 20,260,000 | 22,155,000 | 16,544,000 | 12,028,000 | 9,524,000 | 18,761,000 | 9,974,000 | 8,192,000 |
| total current assets | 463,895,000 | 554,154,000 | 599,310,000 | 587,301,000 | 530,203,000 | 588,733,000 | 716,363,000 | 491,456,000 | 558,070,000 | 571,367,000 | 266,863,000 | 290,305,000 | 325,747,000 | 220,903,000 | 112,809,000 |
| restricted cash, non-current | 2,418,000 | 2,418,000 | 2,418,000 | 2,418,000 | 2,418,000 | 2,418,000 | 2,418,000 | ||||||||
| marketable securities, non-current | 84,502,000 | 21,942,000 | 38,277,000 | 102,428,000 | 130,128,000 | 117,102,000 | 27,168,000 | ||||||||
| property and equipment | 44,472,000 | 45,568,000 | 46,456,000 | 47,497,000 | 46,276,000 | 44,930,000 | 42,728,000 | 37,782,000 | 22,285,000 | 14,421,000 | 11,231,000 | 10,034,000 | 9,660,000 | 10,127,000 | 10,318,000 |
| operating lease right-of-use assets | 23,416,000 | 23,603,000 | 23,789,000 | 23,934,000 | 24,065,000 | 24,196,000 | 27,099,000 | 29,142,000 | 29,386,000 | 29,645,000 | 28,659,000 | 28,969,000 | 27,449,000 | 3,248,000 | |
| prepaid research and development expenses and other long-term assets | 383,000 | 397,000 | 1,077,000 | 1,331,000 | 1,216,000 | 2,316,000 | 9,356,000 | 7,949,000 | 11,286,000 | 5,009,000 | 4,563,000 | 5,518,000 | 9,969,000 | 8,913,000 | |
| total assets | 619,086,000 | 648,082,000 | 711,327,000 | 764,909,000 | 734,306,000 | 779,695,000 | 825,132,000 | 614,218,000 | 623,528,000 | 622,943,000 | 313,817,000 | 337,327,000 | 375,326,000 | 243,390,000 | 128,782,000 |
| liabilities and stockholders’ equity | |||||||||||||||
| current liabilities: | |||||||||||||||
| accounts payable | 2,079,000 | 4,369,000 | 2,095,000 | 5,989,000 | 4,868,000 | 3,099,000 | 2,619,000 | 7,185,000 | 5,693,000 | 4,532,000 | 9,053,000 | 2,962,000 | 7,556,000 | 1,874,000 | 1,333,000 |
| accrued liabilities | 53,034,000 | 43,359,000 | 56,716,000 | 43,038,000 | 42,033,000 | 33,933,000 | 18,302,000 | 16,916,000 | 12,390,000 | 13,997,000 | 11,679,000 | 11,212,000 | 22,059,000 | 14,400,000 | 13,180,000 |
| operating lease liabilities, current portion | 7,416,000 | 7,361,000 | 7,308,000 | 7,253,000 | 7,199,000 | 7,146,000 | 7,501,000 | 6,582,000 | 6,111,000 | 4,947,000 | 2,901,000 | 2,874,000 | 2,313,000 | 370,000 | |
| finance lease liabilities, current portion | 230,000 | 10,865,000 | 19,220,000 | 32,531,000 | 39,283,000 | 48,286,000 | 38,045,000 | 35,294,000 | 33,060,000 | 27,729,000 | |||||
| contract liability to related party | 59,321,000 | 57,372,000 | 59,056,000 | 69,872,000 | 14,970,000 | 31,192,000 | 50,533,000 | ||||||||
| total current liabilities | 121,850,000 | 112,461,000 | 125,405,000 | 137,017,000 | 88,290,000 | 107,901,000 | 118,238,000 | 173,149,000 | 156,114,000 | 166,057,000 | 56,693,000 | 44,777,000 | 32,053,000 | 16,808,000 | 14,845,000 |
| operating lease liabilities, net of current portion | 45,097,000 | 45,831,000 | 46,542,000 | 47,214,000 | 47,872,000 | 47,685,000 | 50,841,000 | 48,096,000 | 40,638,000 | 31,994,000 | 31,299,000 | 29,212,000 | 27,200,000 | 4,844,000 | |
| contract liability to related party, net of current portion | 59,916,000 | 69,447,000 | 82,612,000 | 96,081,000 | |||||||||||
| other non-current liabilities | 3,437,000 | 8,593,000 | 15,048,000 | 14,899,000 | 15,468,000 | ||||||||||
| total liabilities | 226,863,000 | 231,176,000 | 256,535,000 | 281,891,000 | 247,142,000 | 283,122,000 | 339,752,000 | 348,090,000 | 329,861,000 | 319,226,000 | 108,863,000 | 101,043,000 | 59,370,000 | 21,799,000 | 16,918,000 |
| commitments and contingencies | |||||||||||||||
| stockholders’ equity | |||||||||||||||
| common stock | 54,000 | 54,000 | 53,000 | 53,000 | 53,000 | 53,000 | 52,000 | 48,000 | 48,000 | 48,000 | 44,000 | 44,000 | 44,000 | 36,000 | 1,000 |
| additional paid-in capital | 1,003,635,000 | 975,301,000 | 950,719,000 | 930,813,000 | 911,783,000 | 893,710,000 | 874,261,000 | 675,469,000 | 663,614,000 | 649,717,000 | 523,921,000 | 516,437,000 | 510,761,000 | 384,095,000 | 8,615,000 |
| accumulated other comprehensive income | 403,000 | 649,000 | 848,000 | 1,899,000 | -792,000 | -512,000 | 547,000 | 86,000 | |||||||
| accumulated deficit | -611,869,000 | -559,098,000 | -496,828,000 | -449,747,000 | -423,880,000 | -396,678,000 | -389,480,000 | -409,324,000 | -369,988,000 | -346,134,000 | -318,790,000 | -279,798,000 | -194,587,000 | -162,496,000 | -130,111,000 |
| total stockholders’ equity | 392,223,000 | 416,906,000 | 454,792,000 | 483,018,000 | 487,164,000 | 496,573,000 | 485,380,000 | 266,128,000 | 293,667,000 | 303,717,000 | 204,954,000 | 236,284,000 | 315,956,000 | 221,591,000 | |
| total liabilities and stockholders’ equity | 619,086,000 | 648,082,000 | 711,327,000 | 764,909,000 | 734,306,000 | 779,695,000 | 825,132,000 | 614,218,000 | 623,528,000 | 622,943,000 | |||||
| contract liabilities, net of current portion to related party | 75,995,000 | 170,673,000 | |||||||||||||
| stockholders’ equity: | |||||||||||||||
| contract liability, net of current portion to related party | 112,068,000 | ||||||||||||||
| finance lease liabilities, net of current portion | 5,755,000 | 8,841,000 | 15,413,000 | 20,871,000 | 27,054,000 | ||||||||||
| receivable from collaboration partner | 31,480,000 | 29,431,000 | 21,230,000 | ||||||||||||
| restricted cash | 4,929,000 | 2,501,000 | 2,501,000 | 2,501,000 | 2,501,000 | 2,501,000 | 199,000 | 199,000 | |||||||
| marketable securities non current | 42,960,000 | ||||||||||||||
| contract liability | 94,180,000 | 93,875,000 | 107,287,000 | ||||||||||||
| contract liability, net of current portion | 121,090,000 | 124,268,000 | 105,762,000 | ||||||||||||
| preferred stock, par value of 0.001 per share; 200,000,000 shares authorized and no shares issued and outstanding as of september 30, 2023 or december 31, 2022 | |||||||||||||||
| accumulated other comprehensive loss | -65,000 | -7,000 | -221,000 | -399,000 | -262,000 | -44,000 | -20,000 | ||||||||
| preferred stock, par value of 0.001 per share; 200,000,000 shares authorized and no shares issued and outstanding as of june 30, 2023 or december 31, 2022 | |||||||||||||||
| preferred stock, par value of 0.001 per share; 200,000,000 shares authorized and no shares issued and outstanding as of march 31, 2023 or december 31, 2022 | |||||||||||||||
| deferred offering costs | 3,172,000 | ||||||||||||||
| liabilities, redeemable convertible preferred stock, and stockholders’ equity | |||||||||||||||
| deferred rent, current portion | 183,000 | ||||||||||||||
| other current liabilities | 125,000 | 164,000 | 149,000 | ||||||||||||
| deferred rent, net of current portion | 1,895,000 | ||||||||||||||
| other long-term liabilities | 117,000 | 147,000 | 178,000 | ||||||||||||
| redeemable convertible preferred stock | |||||||||||||||
| series a redeemable convertible preferred stock, par value 0.001 per share; no shares authorized, issued or outstanding as of december 31, 2022; 29,795,227 shares authorized and 5,413,272 shares issued and outstanding as of december 31, 2021; liquidation value of 0 and 29,795 as of december 31, 2022 and december 31, 2021, respectively | |||||||||||||||
| series b redeemable convertible preferred stock, par value 0.001 per share; no shares authorized, issued or outstanding as of december 31, 2022; 49,402,623 shares authorized and 8,975,585 shares issued and outstanding as of december 31, 2021; liquidation value of 0 and 85,681 as of december 31, 2022 and december 31, 2021, respectively | |||||||||||||||
| series c redeemable convertible preferred stock, par value 0.001 per share; no shares authorized, issued or outstanding as of december 31, 2022; 57,224,618 shares authorized and 10,396,707 shares issued and outstanding as of december 31, 2021; liquidation value of 0 and 120,000 as of december 31, 2022 and december 31, 2021, respectively | |||||||||||||||
| total redeemable convertible preferred stock | 233,379,000 | ||||||||||||||
| preferred stock, par value of 0.001 per share; 200,000,000 shares authorized and no shares issued and outstanding as of december 31, 2022; no shares authorized, issued or outstanding as of december 31, 2021 | |||||||||||||||
| total liabilities, redeemable convertible preferred stock, and stockholders’ equity | 313,817,000 | 337,327,000 | 375,326,000 | 243,390,000 | |||||||||||
| series a redeemable convertible preferred stock, par value 0.001 per share; no shares authorized, issued or outstanding as of september 30, 2022; 29,795,227 shares authorized and 5,413,272 shares issued and outstanding as of december 31, 2021; liquidation value of 0 and 29,795 as of september 30, 2022 and december 31, 2021, respectively | |||||||||||||||
| series b redeemable convertible preferred stock, par value 0.001 per share; no shares authorized, issued or outstanding as of september 30, 2022; 49,402,623 shares authorized and 8,975,585 shares issued and outstanding as of december 31, 2021; liquidation value of 0 and 85,681 as of september 30, 2022 and december 31, 2021, respectively | |||||||||||||||
| series c redeemable convertible preferred stock, par value 0.001 per share; no shares authorized, issued or outstanding as of september 30, 2022; 57,224,618 shares authorized and 10,396,707 shares issued and outstanding as of december 31, 2021; liquidation value of 0 and 120,000 as of september 30, 2022 and december 31, 2021, respectively | |||||||||||||||
| preferred stock, par value of 0.001 per share; 200,000,000 shares authorized and no shares issued and outstanding as of september 30, 2022; no shares authorized, issued or outstanding as of december 31, 2021 | |||||||||||||||
| series a redeemable convertible preferred stock, par value 0.001 per share; no shares authorized, issued or outstanding as of june 30, 2022; 29,795,227 shares authorized and 5,413,272 shares issued and outstanding as of december 31, 2021; liquidation value of 0 and 29,795 as of june 30, 2022 and december 31, 2021, respectively | |||||||||||||||
| series b redeemable convertible preferred stock, par value 0.001 per share; no shares authorized, issued or outstanding as of june 30, 2022; 49,402,623 shares authorized and 8,975,585 shares issued and outstanding as of december 31, 2021; liquidation value of 0 and 85,681 as of june 30, 2022 and december 31, 2021, respectively | |||||||||||||||
| series c redeemable convertible preferred stock, par value 0.001 per share; no shares authorized, issued or outstanding as of june 30, 2022; 57,224,618 shares authorized and 10,396,707 shares issued and outstanding as of december 31, 2021; liquidation value of 0 and 120,000 as of june 30, 2022 and december 31, 2021, respectively | |||||||||||||||
| preferred stock, par value of 0.001 per share; 200,000,000 shares authorized and no shares issued and outstanding as of june 30, 2022; no shares authorized, issued or outstanding as of december 31, 2021 | |||||||||||||||
| series a redeemable convertible preferred stock, par value 0.001 per share; no shares authorized, issued or outstanding as of march 31, 2022; 29,795,227 shares authorized and 5,413,272 shares issued and outstanding as of december 31, 2021; liquidation value of 0 and 29,795 as of march 31, 2022 and december 31, 2021, respectively | |||||||||||||||
| series b redeemable convertible preferred stock, par value 0.001 per share; no shares authorized, issued or outstanding as of march 31, 2022; 49,402,623 shares authorized and 8,975,585 shares issued and outstanding as of december 31, 2021; liquidation value of 0 and 85,681 as of march 31, 2022 and december 31, 2021, respectively | |||||||||||||||
| series c redeemable convertible preferred stock, par value 0.001 per share; no shares authorized, issued or outstanding as of march 31, 2022; 57,224,618 shares authorized and 10,396,707 shares issued and outstanding as of december 31, 2021; liquidation value of 0 and 120,000 as of march 31, 2022 and december 31, 2021, respectively | |||||||||||||||
| preferred stock, par value of 0.001 per share; 200,000,000 shares authorized and no shares issued and outstanding as of march 31, 2022; no shares authorized, issued or outstanding as of december 31, 2021 | |||||||||||||||
| other long-term assets | 2,284,000 | ||||||||||||||
| liabilities, redeemable convertible preferred stock, and stockholders’ deficit | |||||||||||||||
| series a redeemable convertible preferred stock, par value of 0.001 per share; 29,795,227 shares authorized at december 31, 2021 and 2020; 5,413,272 shares issued and outstanding at december 31, 2021 and 2020; liquidation value 29,795 at december 31, 2021 and 2020. | 28,894,000 | ||||||||||||||
| series b redeemable convertible preferred stock, par value 0.001 per share; 49,402,623 shares authorized at december 31, 2021 and 2020; 8,975,585 shares issued and outstanding at december 31, 2021 and 2020; liquidation value of 85,681 at december 31, 2021 and 2020. | 85,367,000 | ||||||||||||||
| series c redeemable convertible preferred stock, par value 0.001 per share; 57,224,618 shares and 0 authorized at december 31, 2021 and 2020, respectively; 10,396,707 and 0 shares issued and outstanding at december 31, 2021 and 2020, respectively; liquidation value of 120,000 and 0 at december 31, 2021 and 2020, respectively. | 119,118,000 | ||||||||||||||
| stockholders’ deficit: | |||||||||||||||
| total stockholders’ deficit | -121,515,000 | ||||||||||||||
| total liabilities, redeemable convertible preferred stock, and stockholders’ deficit | 128,782,000 | ||||||||||||||
| revenue | |||||||||||||||
| operating expenses: | |||||||||||||||
| research and development | 46,883,000 | ||||||||||||||
| general and administrative | 18,135,000 | ||||||||||||||
| total operating expenses | 65,018,000 | ||||||||||||||
| income from operations | -65,018,000 | ||||||||||||||
| other income | 49,000 | ||||||||||||||
| net income | -64,969,000 | ||||||||||||||
| other comprehensive loss: | |||||||||||||||
| unrealized loss on marketable securities | 20,000 | ||||||||||||||
| comprehensive loss | -64,989,000 | ||||||||||||||
| net income per share | -145,550 | ||||||||||||||
| weighted-average common shares outstanding—basic and diluted | 446,379,000 |
We provide you with 20 years of balance sheets for Arcellx stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Arcellx. Explore the full financial landscape of Arcellx stock with our expertly curated balance sheets.
The information provided in this report about Arcellx stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.